Literature DB >> 18003692

Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance.

H Chung1, R Refoios Camejo, R R Camejo, D Barnett.   

Abstract

This NICE technology appraisal guidance considers the clinical and cost effectiveness of the use of alteplase for acute ischaemic stroke.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18003692      PMCID： PMC2095758          DOI： 10.1136/hrt.2007.132894

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  5 in total

1.  ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

Authors:  Gregory W Albers; Wayne M Clark; Kenneth P Madden; Scott A Hamilton
Journal:  Stroke       Date:  2002-02       Impact factor: 7.914

2.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

3.  Findings from the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.

Authors:  Timothy John Ingall; William Michael O'Fallon; Kjell Asplund; Lewis Robert Goldfrank; Vicki S Hertzberg; Thomas Arthur Louis; Teresa J Hengy Christianson
Journal:  Stroke       Date:  2004-09-02       Impact factor: 7.914

4.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

Review 5.  Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal.

Authors:  M Lloyd Jones; M Holmes
Journal:  Health Technol Assess       Date:  2009-09       Impact factor: 4.014
  5 in total
  4 in total

1.  Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Maarten G Lansberg; Martin J O'Donnell; Pooja Khatri; Eddy S Lang; Mai N Nguyen-Huynh; Neil E Schwartz; Frank A Sonnenberg; Sam Schulman; Per Olav Vandvik; Frederick A Spencer; Pablo Alonso-Coello; Gordon H Guyatt; Elie A Akl
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Assessment of factors associated with prominent changes in blood pressure during an early mobilization protocol for patients with acute ischemic stroke after mechanical thrombectomy.

Authors:  Maiko Yagi; Sato Watanabe; Chika Kondo; Yukiko Kaihoko; Koji Endo; Fumio Miyashita; Tatsuro Takada; Toshihiro Ueda
Journal:  Phys Ther Res       Date:  2016-07-13

3.  Protocol for an observation and implementation study investigating optimisation of the management of stroke and transient ischaemic attack (TIA).

Authors:  James Peter Sheppard; Ruth Mary Mellor; Sheila Marie Bailey; Pelham Barton; Amunpreet Boyal; Sheila Greenfield; Sue Jowett; Jonathan Mant; Tom Quinn; Satinder Singh; Richard J McManus
Journal:  BMJ Open       Date:  2012-06-25       Impact factor: 2.692

4.  Translating research into practice: lessons from trials of thrombolysis in acute stroke.

Authors:  Graham Venables
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.